Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Board Review
CME
Careers
Cases
Conferences
Videos
Webinars
Podcasts
Advertising
Buyer's Guide
Vendors
Minnies
Resources: Page 438
Ga-68 DOTA-NOC tops F-18 DOPA-PET/CT for neuroendocrine tumors
By
Wayne Forrest
Tuesday, November 29 | 10:50 a.m.-11:00 a.m. | SSG12-03 | Room S505ABIn a comparison with F-18 DOPA-PET/CT, gallium-68 (Ga-68) DOTA-NOC achieved "superior sensitivity" with neuroendocrine tumors, prompting researchers to conclude that Ga-68 DOTA-NOC could help direct more effective patient treatment.
November 7, 2011
Researchers look for link between veterans' motor issues and brain injuries
By
Wayne Forrest
Monday, November 28 | 3:20 p.m.-3:30 p.m. | SSE19-03 | Room S505ABWith the help of FDG-PET, researchers at the University of Washington are investigating a possible link between Parkinsonian motor symptoms and blast-related mild traumatic brain injury among Iraq and Afghanistan war veterans.
November 7, 2011
FDG-PET/CT shows steroid therapy impact on pulmonary nodules
By
Wayne Forrest
Monday, November 28 | 11:40 a.m.-11:50 a.m. | SSC14-08 | Room S505ABA pilot study at Children's Hospital of Michigan is seeking to determine whether 40 hours of steroid therapy can help characterize equivocal pulmonary nodules in FDG-PET/CT scans.
November 7, 2011
Study questions SUVmax role in solitary pulmonary nodule malignancy
By
Wayne Forrest
Monday, November 28 | 11:20 a.m.-11:30 a.m. | SSC14-06 | Room S505ABResearchers at Thomas Jefferson University are challenging the traditional belief that a decrease in glucose metabolism demonstrated by a solitary pulmonary nodule during the delayed phase of dual-point FDG-PET/CT indicates that the nodule is benign.
November 7, 2011
Novel molecular imaging technique could help prostate cancer patients
By
Wayne Forrest
Monday, November 28 | 11:20 a.m.-11:30 a.m. | SSC09-06 | Room S504CDIn this paper presentation, Dutch researchers will show early promising results for two novel molecular imaging techniques to detect and manage lymph node metastases in prostate cancer patients.
November 7, 2011
FDG-PET/CT predicts early response to chemo in NSCLC patients
By
Wayne Forrest
Monday, November 28 | 11:00 a.m.-11:10 a.m. | SSC14-04 | Room S505ABFDG-PET/CT is showing its prowess in predicting non-small cell lung cancer (NSCLC) tumor metabolic response and length of survival one and five weeks after the start of chemotherapy treatment.
November 7, 2011
Breast imaging benefits from both PET/CT and PET/MRI
By
Wayne Forrest
Sunday, November 27 | 11:05 a.m.-11:15 a.m. | SSA18-03 | Room S505ABBreast imaging can benefit from contrast-enhanced PET/CT, and even better results can be achieved with PET/MRI, according to a study by researchers from Kochi University Hospital in Japan.
November 7, 2011
Medspira to show upgraded Breath Hold
By
AuntMinnie.com staff writers
Respiratory motion monitoring technology developer Medspira plans to show an advanced version of its Breath Hold standalone system for multiple imaging modalities at this month's RSNA meeting in Chicago.
November 6, 2011
iPad supports image transfer to ICU
By
Erik L. Ridley
Tuesday, November 29 | 10:30 a.m.-10:40 a.m. | MSVR31-10 | Room N228In this paper, a Massachusetts General Hospital team will share how the iPad can bridge the gap between intensivists and radiologists.
November 6, 2011
iPad overcomes iPhone limitations for head CT
By
Erik L. Ridley
Tuesday, November 29 | 10:20 a.m.-10:30 a.m. | MSVR31-09 | Room N228A Massachusetts General Hospital team found the iPad could improve on the iPhone's performance in diagnosing head CT.
November 6, 2011
iPad proves up for challenge of detecting pneumothorax
By
Erik L. Ridley
Tuesday, November 29 | 10:10 a.m.-10:20 a.m. | MSVR31-08 | Room N228In this paper, researchers found the iPad held its own in a comparison study with a PACS workstation for detecting pneumothorax on chest radiographs.
November 6, 2011
Road to RSNA 2011: PACS Preview
By
Erik L. Ridley
PACS technology is always a hot topic at the RSNA meeting, and this year will be no different. Interest in mobile devices continues to explode, no doubt aided by the U.S. Food and Drug Administration's decision in early 2011 to clear an application for diagnostic use on Apple's iPad and iPhone.
November 6, 2011
Previous Page
Page 438 of 726
Next Page